Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marie-Anne Vandenhende

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Infection|May 5, 2018
Gamma delta T cell expansion in Whipple's disease with muscular granulomatous vasculitisDidier Brönnimann, Marie-Anne Vandenhende, Jean-François Viallard
Joint Bone Spine|May 10, 2011
Anakinra: an effective treatment in the Schnitzler syndromeMarie-Anne Vandenhende, Fabrice Bentaberry, Philippe Morlat, et al.
Diagnostic Microbiology and Infectious Disease|February 15, 2014
Successful daptomycin lock therapy for implantable intra-arterial catheter infection in a patient with liver metastases of colon cancerMarie-Anne Vandenhende, Jennifer Buret, Fabrice Camou, et al.
Autoimmunity Reviews|July 4, 2013
Tocilizumab in refractory Takayasu arteritis: a case series and updated literature reviewNoémie Abisror, Arsene Mekinian, Christian Lavigne, et al.
RMD Open|September 8, 2017
Treatment of polyarteritis nodosa with tocilizumab: a new therapeutic approach?Aurélie Saunier, Nahéma Issa, Marie-Anne Vandenhende, et al.
La Revue De Medecine Interne|June 25, 2022
[Hearing loss in giant cell arteritis: A case report]Pedro De Fontcuberta, Marie-Anne Vandenhende, Miranda Laux, et al.
AIDS Research and Human Retroviruses|July 31, 2013
Detection of low-frequency HIV type 1 reverse transcriptase drug resistance mutations by ultradeep sequencing in naive HIV type 1-infected individualsPantxika Bellecave, Patricia Recordon-Pinson, Jennifer Papuchon, et al.
Antiviral Therapy|March 5, 2015
Risk of virological failure in HIV-1-infected patients experiencing low-level viraemia under active antiretroviral therapy (ANRS C03 cohort study)Marie-Anne Vandenhende, Adélaïde Perrier, Fabrice Bonnet, et al.
Infectious Diseases Now|February 3, 2024
Central venous catheter-related bloodstream infections: Epidemiology and risk factors for hematogenous complicationsElisabeth Carolle Ngo Bell, Virginie Chapon, Emilie Bessede, et al.
Journal of Hepatology|March 1, 2011
HIV-induced immune deficiency is associated with a higher risk of hepatocarcinoma, ANRS CO3 Aquitaine Cohort, France, 1998-2008Mathias Bruyand, François Dabis, Marie-Anne Vandenhende, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Infection|May 5, 2018
Gamma delta T cell expansion in Whipple's disease with muscular granulomatous vasculitisDidier Brönnimann, Marie-Anne Vandenhende, Jean-François Viallard
Joint Bone Spine|May 10, 2011
Anakinra: an effective treatment in the Schnitzler syndromeMarie-Anne Vandenhende, Fabrice Bentaberry, Philippe Morlat, et al.
Diagnostic Microbiology and Infectious Disease|February 15, 2014
Successful daptomycin lock therapy for implantable intra-arterial catheter infection in a patient with liver metastases of colon cancerMarie-Anne Vandenhende, Jennifer Buret, Fabrice Camou, et al.
Autoimmunity Reviews|July 4, 2013
Tocilizumab in refractory Takayasu arteritis: a case series and updated literature reviewNoémie Abisror, Arsene Mekinian, Christian Lavigne, et al.
RMD Open|September 8, 2017
Treatment of polyarteritis nodosa with tocilizumab: a new therapeutic approach?Aurélie Saunier, Nahéma Issa, Marie-Anne Vandenhende, et al.
La Revue De Medecine Interne|June 25, 2022
[Hearing loss in giant cell arteritis: A case report]Pedro De Fontcuberta, Marie-Anne Vandenhende, Miranda Laux, et al.
AIDS Research and Human Retroviruses|July 31, 2013
Detection of low-frequency HIV type 1 reverse transcriptase drug resistance mutations by ultradeep sequencing in naive HIV type 1-infected individualsPantxika Bellecave, Patricia Recordon-Pinson, Jennifer Papuchon, et al.
Antiviral Therapy|March 5, 2015
Risk of virological failure in HIV-1-infected patients experiencing low-level viraemia under active antiretroviral therapy (ANRS C03 cohort study)Marie-Anne Vandenhende, Adélaïde Perrier, Fabrice Bonnet, et al.
Infectious Diseases Now|February 3, 2024
Central venous catheter-related bloodstream infections: Epidemiology and risk factors for hematogenous complicationsElisabeth Carolle Ngo Bell, Virginie Chapon, Emilie Bessede, et al.
Journal of Hepatology|March 1, 2011
HIV-induced immune deficiency is associated with a higher risk of hepatocarcinoma, ANRS CO3 Aquitaine Cohort, France, 1998-2008Mathias Bruyand, François Dabis, Marie-Anne Vandenhende, et al.
Pageof 3